TIL Q1 2021 Earnings — Instil Bio, Inc. Revenue & Financial Results | Market Cap Arena

TILInstil Bio, Inc.

$60M

Q1 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

$0

Operating Income

-$23M

Net Income

-$23M

EPS (Diluted)

$-0.66

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$18M

Free Cash Flow

-$27M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$696M

Total Liabilities

$31M

Stockholders' Equity

$665M

Cash & Equivalents

$610M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$44,000	-100.0%
Gross Profit	$0	$44,000	-100.0%
Operating Income	-$23M	-$4M	-505.8%
Net Income	-$23M	-$4M	-465.6%